We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Teva, Par Lose Patent Case on GSK Heart Drug Lovaza
Teva, Par Lose Patent Case on GSK Heart Drug Lovaza
June 5, 2012
A Delaware federal judge has upheld two patents covering GlaxoSmithKline’s heart drug Lovaza.